Is a controlled trial of long-term oral anticoagulants in patients with stroke and non-rheumatic atrial fibrillation worthwhile?
A controlled randomised trial large enough to assess the value of anticoagulating stroke patients in atrial fibrillation would be difficult to conduct in the UK and the results would be applicable to only a small proportion of stroke patients. It would be more worthwhile to organise a trial that als...
Autores principales: | Sandercock, P, Warlow, C, Bamford, J, Peto, R, Starkey, I |
---|---|
Formato: | Journal article |
Lenguaje: | English |
Publicado: |
1986
|
Ejemplares similares
-
Rivaroxaban as an oral anticoagulant for stroke prevention in atrial fibrillation
por: Turpie AGG
Publicado: (2014-03-01) -
A new era of anticoagulant therapy in the prevention of stroke in non-rheumatic atrial fibrillation
por: Andrei Viktorovich Fonyakin, et al.
Publicado: (2012-09-01) -
Adherence to oral anticoagulation in ischemic stroke patients with atrial fibrillation
por: Paula Tiili, et al.
Publicado: (2021-01-01) -
Old and new oral anticoagulants for secondary stroke prevention in atrial fibrillation
por: Tommaso Sacquegna, et al.
Publicado: (2015-12-01) -
Prevalence of oral anticoagulation in atrial fibrillation
por: Eduardo Bartholomay, et al.
Publicado: (2014-09-01)